← Leaderboards
Ming C Gong
University Of Kentucky
$10,288,417
Attributed
$17,953,344
Total exposure
9
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.1M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,953,344 · 9
By mechanism
R01$17,953,344 · 9
Top collaborators
- Zhenheng Guo26 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Zhenheng Guo$9,758,888
- Luksana Chaiswing$2,437,340
- Javier A. Neyra$4,703,171
- John Joseph Mc Carthy$7,212,078
- Radhika Anand Vaishnav$60,012
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectHypertensionDiabetes MellitusAgonistLinkGenesKnockout MiceSchemeSignal TransductionPre-ClinicalBlood PressureMolecularMaleInsightDiabeticDb/Db MouseDiabetic MouseNovel TherapeuticsArntl GeneCardiovascular SystemCardiovascular DiseasesMediatingDiabetic PatientAnimals
Grant awards (35)
Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females$721,911
R01 · FY2025 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes$695,237
R01 · FY2025 · HL · contact PI
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis$664,969
R01 · FY2025 · HL
Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females$721,911
R01 · FY2024 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes$681,332
R01 · FY2024 · HL · contact PI
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis$651,670
R01 · FY2024 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes$695,237
R01 · FY2023 · HL · contact PI
Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis$664,969
R01 · FY2023 · HL
Targeting GLP-1 receptor as a new chronotherapy against nondipping blood pressure in diabetes$695,237
R01 · FY2022 · HL · contact PI
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes$601,123
R01 · FY2022 · HL · contact PI
A novel mechanism by which smooth muscle BMAL1 regulates IL-6 and sexual dimorphism of abdominal aortic aneurysm$641,381
R01 · FY2021 · HL · contact PI
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes$601,123
R01 · FY2021 · HL · contact PI
A novel mechanism by which smooth muscle BMAL1 regulates IL-6 and sexual dimorphism of abdominal aortic aneurysm$626,752
R01 · FY2020 · HL · contact PI
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes$601,123
R01 · FY2020 · HL · contact PI
Targeting timing of food intake as a novel strategy against disruption of blood pressure circadian rhythm in diabetes$704,321
R01 · FY2019 · HL · contact PI
A novel mechanism by which smooth muscle BMAL1 regulates IL-6 and sexual dimorphism of abdominal aortic aneurysm$626,335
R01 · FY2019 · HL · contact PI
A novel mechanism by which smooth muscle BMAL1 regulates IL-6 and sexual dimorphism of abdominal aortic aneurysm$680,654
R01 · FY2018 · HL · contact PI
Mineralocorticoid receptor and abdominal aortic aneurysm$519,619
R01 · FY2018 · HL · contact PI
Mineralocorticoid receptor and abdominal aortic aneurysm$519,619
R01 · FY2017 · HL · contact PI
Mineralocorticoid receptor and abdominal aortic aneurysm$519,619
R01 · FY2016 · HL · contact PI
Mineralocorticoid receptor and abdominal aortic aneurysm$531,469
R01 · FY2015 · HL · contact PI
Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1$468,797
R01 · FY2015 · HL · contact PI
Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1$466,417
R01 · FY2014 · HL · contact PI
Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1$100,000
R01 · FY2014 · HL · contact PI
Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1$453,093
R01 · FY2013 · HL · contact PI
Regulation of Blood Pressure Circadian Rhythm by Vascular Smooth Muscle BMAL1$475,937
R01 · FY2012 · HL · contact PI
Vascular Smooth Muscle Hyper-contractility and Hypertension in Type-II-Diabetes$320,066
R01 · FY2010 · HL · contact PI
Vascular Smooth Muscle Hyper-contractility and Hypertension in Type-II-Diabetes$320,066
R01 · FY2009 · HL · contact PI
Vascular Smooth Muscle Hyper-contractility and Hypertension in Type-II-Diabetes$320,066
R01 · FY2008 · HL · contact PI
Vascular Smooth Muscle Hyper-contractility and Hypertension in Type-II-Diabetes$320,066
R01 · FY2007 · HL · contact PI
Vascular Smooth Muscle Hyper-contractility/Hypertension$329,625
R01 · FY2006 · HL · contact PI
Regulation of Vascular Smooth Muscle Contracting$253,400
R01 · FY2005 · HL
Regulation of Vascular Smooth Muscle Contracting$253,400
R01 · FY2004 · HL
Regulation of Vascular Smooth Muscle Contracting$253,400
R01 · FY2003 · HL
Regulation of Vascular Smooth Muscle Contracting$253,400
R01 · FY2002 · HL